• Weight management and body composition research
• Appetite regulation and satiety signaling studies
• Triple hormone receptor pathway investigations (GLP-1, GIP, and Glucagon)
• Fat metabolism and energy expenditure research
• Obesity and overweight management studies
• Metabolic wellness and insulin sensitivity research
• Blood glucose regulation investigations
• Cardiometabolic health and risk factor studies
• Non-alcoholic fatty liver disease (NAFLD) research
• Long-term weight maintenance strategies
• Energy balance and metabolic flexibility research
• Advanced obesity treatment and metabolic health studies
Mechanism of Interest Retatrutide is a triple receptor agonist that targets GLP-1, GIP, and glucagon receptors. Researchers are studying its potential to support weight management through multiple complementary pathways, including appetite reduction, improved metabolic function, enhanced energy expenditure, and fat metabolism.
